Possible role for cellular FXIII in monocyte-derived dendritic cell motility by Jayo, Asier et al.
1Possible role for cellular FXIII in monocyte-derived dendritic cell motility
Asier Jayo,* Isabel Conde,* Pedro Lastres,* Victor Jiménez-Yuste,† and Consuelo 
González-Manchón*,‡
*Department of Cellular and Molecular Physiopathology, Centro de Investigaciones 
Biológicas (CSIC), Madrid, Spain; †Laboratory of Hematology, Hospital Universitario 
La Paz, Madrid, Spain; and ‡Centro de Investigación Biomédica en Red de 
Enfermedades Raras (CIBERER)
Running title: cFXIII and dendritic cell motility
Correspondence: Consuelo González-Manchón, Department of Cellular and Molecular 
Physiopathology, Centro de Investigaciones Biológicas, Ramiro de Maeztu 9, 28040 
Madrid, Spain. Phone: 34-91-8373112; Fax: 34-91-5360432; E-mail: 
cgmanchon@cib.csic.es
Acknowledgments
This work was supported by grants from the Dirección General de Investigación del 
Ministerio de Educación y Ciencia (BFU2006-00914) and Fundación Rodríguez 
Pascual. A. Jayo was recipient of a fellowship from the Ministerio de Educación y 
Ciencia. I. Conde holds a research contract from the Consejo Superior de 
Investigaciones Científicas. We thank María Teresa Seisdedos for confocal microscopy 
technical assistance.
Manuscript
2Abstract
The A subunit of plasma factor XIII (FXIII-A) is thought to function as an 
intracellular transglutaminase (TG) in the monocyte/macrophage lineage to regulate 
certain intracellular processes involving cytoskeleton remodeling, but its precise role 
and the functional consequences of its absence remain poorly understood. In the present 
study, we show that FXIII-A expression is largely upregulated during in vitro
differentiation of monocytes into dendritic cells (DCs). Monodansyl-cadaverine, a 
competitive substrate of TG activity, inhibited basal and CCL19-stimulated migration of 
mature DCs. In aggrement, FXIII-A-deficient DCs showed a reduced chemotactic 
response to CCL19. Consistent with these findings, CHO cells stably expressing human 
FXIII-A showed enhanced motility in transwell and scratch-wound assays. These cells 
displayed increased formation of membrane blebs, dynamic cell protrusions implicated 
in cell movement that were also observed in DCs. The results provide evidence 
suggesting that upregulation of cFXIII in DCs has a role in regulating cell motility.
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3Introduction
FXIII is a transglutaminase (TG) that circulates in plasma as a heterotetramer A2B2
composed of two catalytic A and two regulatory B subunits (Muszbek et al., 1999; 
Lorand and Graham, 2003). It becomes activated by Ca2+ and thrombin at the final stage 
of blood coagulation, crosslinking fibrin  and  chains to stabilize the clot (Muszbek et 
al., 1999). Besides its role in hemostasis, work in the last three decades has revealed its 
participation in wound healing and pregnancy maintenance (Gierhake et al., 1970; 
Asahina et al., 2000; Lorand, 2005). A variety of mutations and splicing defects have 
been described in the FXIII subunit genes associated with bleeding tendency and 
plasma FXIII deficiency (Ichinose, 2001). Most identified mutations involve subunit A, 
with very few mutations reported in subunit B 
(http://www.hgmd.cf.ac.uk/ac/index.php). The incidence of this disease, in the range of 
1 in 5 million, is increasing as more laboratory support becomes available around the 
world. FXIII deficiency results in delayed bleeding after trauma and impaired wound 
healing, while primary hemostasis is apparently normal. Umbilical bleeding in the first 
days after birth, repeated intracranial hemorrhages and recurrent early miscarriages are 
characteristics of the disease.
The A subunit dimer, FXIII-A2, functions as an intracellular TG in the 
megakaryocyte/ platelet and monocyte/macrophage lineages where it can be activated 
by low Ca2+ concentrations in the absence of thrombin (Polgar et al., 1990; Siebenlist et 
al., 2001; Adany and Bardos, 2003). Platelets contain large amounts of the FXIII-A 
while the concentration in monocytes is at least one magnitude less than that in platelets 
(Muszbek et al., 1999). This cellular form of FXIII (cFXIII) is assumed to regulate 
certain intracellular processes involving cytoskeleton remodeling during cell activation, 
but its precise role and the functional consequences of its absence remain poorly 
understood (Adany and Bardos, 2003). Due to the severity of bleeding as a consequence 
of plasma FXIII deficiency, it has been difficult to determine whether patients with 
mutations in FXIII-A subunit have a distinctive phenotype associated to the concurrent 
lack of cellular FXIII.
In the last years several works have provided insights on the functional significance 
of the presence of FXIII-A in the monocyte/macrophage lineage. A recent study with 
FXIII-A-deficient monocytes suggests that it may play a role in Fc and complement 
receptor-mediated phagocytosis (Sarvary et al., 2004). Further, it has been identified as 
a marker of alternative macrophage activation (Torocsik et al., 2005). Moreover, the TG 
activity of cFXIII seems to play a role in receptor dimerization and increase of 
monocyte adhesion to endothelial cells at the onset of atherosclerosis (AbdAlla et al., 
2004). FXIII-A is also expressed in some subpopulations of dendritic cells (DCs) such 
as migratory dermal DCs (Nestle et al., 1993), DC-like cells derived from CD34+ 
progenitor cells (Caux et al., 1996), a subset of dermal cells termed ¨dermal 
dendrocytes¨ (Cerio et al., 1989; Quatresooz et al., 2008), and in vitro monocyte-derived 
DCs (Grassi et al., 1998). It has also been recently identified in a population of dermal 
cells with a marked plasticity between tissue-resident DCs and macrophages (Zaba et 
al., 2007), suggesting that FXIII-A expression may associate to an alternative cellular 
activation state following the stimulation of DCs and macrophages by IL-4 (Nestle and 
Nickoloff, 2007).
In the present report we first examined the relative expression of FXIII-A in 
monocytes and monocyte-derived DCs. Using this cellular model as well as stable cell 
transfectants, we analyzed the distribution pattern of FXIII-A and investigated whether 
it could have a role in regulating cell migration.
4Materials and methods
Patient
The FXIII-deficient patient carried the Gly562Arg mutation in homozygosis in the A 
subunit. The absence of cFXIII was demonstrated by western and fluorescence 
microscopy analysis of platelets and dendritic cells. This mutation has been previously 
identified in other patient. Although normally synthesized, FXIII-A carrying Gly562Arg 
was reported to rapidly disappear in transfected cells, suggesting an altered 
conformation leading to rapid degradation (Takahashi et al., 1998).
This study was approved by the hospital ethics Committee, and written informed 
consent for the use of blood sampling was obtained from the patient and controls in 
accordance with the Declaration of Helsinki.
PCR-based relative quantification of FXIII-A and TG2 mRNA
To determine the relative expression of FXIII-A in different human cell types, a 
series of 30 L-reverse transcription reactions were performed using the antisense 
oligonucleotide 5’-AGGATGCCATCTTCAAACTG-3’. Then, 5 L-aliquots were used 
as template in 20, 25, 30, and 35-cycle PCR reactions, using the sense oligonucleotide 
5’-GTCTGTGCGGCTGTCCATC-3’ to amplify a FXIII-A-cDNA fragment of 285-bp. 
Amplification of a 163-bp fragment of -actin-cDNA was carried out in parallel to 
verify that similar amounts of total RNA were used. 
In order to compare the relative expression of FXIII-A and TG2 in monocytes and 
DCs, a series of 50 L-reverse transcription reactions were performed using random 
antisense oligonucleotides. 2 L-aliquots were used as template in 25, 30, 35 and 40-
cycle PCR reactions using the antisense oligonucleotide described above that targets 
sequences shared by both TG2 and FXIII-A, and specific sense oligonucleotides, 5’-
GTCTGTGCGGCTGTCCATC-3’ and 5’-GCAAGACTGCACCTCG-3’, to amplify 
285-bp cDNA fragments of FXIII-A and TG2, respectively. The amplification products 
were then resolved on agarose gels, visualized by ethidium bromide staining, and 
analyzed by densitometry.
Cell culture and DC differentiation
Human PBMC were isolated from whole blood samples by Lymphoprep (Nycomed) 
gradient centrifugation. To obtain monocyte-enriched populations PBMC were allowed 
to adhere to serum-coated flasks for 1 h at 37ºC, or immuno-sorted using anti-CD41 
coupled to magnetic microbeads (Milteny Biotec, Auburn, CA, USA). Monocytes were 
used to derive mature DCs as previously described (Sallusto and Lanzavecchia, 1994). 
Briefly, cells at 0.5x106/mL were cultured for 6-7 days in complete medium 
supplemented with GM-CSF (1000 U/mL) and IL-4 (1000 U/mL) (Immunotools, 
Friesoythe, Germany) every second day. Then, cytokines and LPS (0.5 μg/mL) 
(SIGMA) were added for an additional 36-h period to induce DC maturation. 
Chinese hamster ovary (CHO) cells were transfected with FXIII-A-cDNA cloned 
into the pIRES2-EGFP expression vector using the calcium phosphate precipitation 
procedure. Transfected cells were grown in medium containing G-418 for three weeks, 
and clonal and pooled cell populations were isolated by cell sorting (FACS Vantage 
Cell Sorter, Becton Dickinson) and characterized for their FXIII-A protein expression 
levels using western and immunofluorescence microscopy analysis.
Cell migration assays
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through a polycarbonate filter (5-μm and 8-μm pore size for DCs and CHO cells, 
respectively) in 24-well transwell chambers (Costar Europe). 105 cells resuspended in 
100 μL of media supplemented with 0.1% BSA were placed in the upper chamber and 
allowed to migrate to the lower chamber containing CCL19 (200 ng/mL) or 10% FCS, 
for DCs or CHO cells, respectively. After 2 h at 37ºC, cells in the lower chamber were 
counted by flow cytometry (Coulter flow cytometer model EPICS XL). CHO cells 
adhered to the lower side of the membrane were first harvested by incubation in 
PBS/EDTA. The percentage of migration was referred to the total number of cells in the 
input sample. For immunofluorescence detection of FXIII-A positive cells, the transwell 
filters were fixed and the cells stained as described in the next section.
For scratch-wound assays CHO cells were seeded into 24-well plates and cultured to 
nearly confluent cell monolayers. Cells were scratched using sterile pipette tips, washed 
with PBS, and incubated with medium supplemented with 1% FCS. Micrographs were 
taken at specific locations immediately after wounding and 3, 6, and 9 h later. Cell 
migration was quantified by measuring the distance between the wound edges before 
and after migration at three distinct positions using computer-assisted microscopy.
Fluorescence microscopy
Cells adhered to glass coverslips were fixed for 15 min in 4% paraformaldehyde in 
PBS, and blocked and permeabilized with 0.5% Triton X-100 in PBS-0.5% BSA for 20 
min at room temperature. Then, cells were incubated with anti-FXIII-A polyclonal 
antibody (USBiological, Swanmpscott, MA, USA) and/or anti-vinculin mAb (Sigma-
Aldrich) in PBS containing 0.1% Triton X-100 and 10% normal goat serum for 1 h. 
After washing with PBS, cells were incubated with Alexa Fluor 488-conjugated anti-
rabbit and/or Alexa Fluor 647-conjugated anti-mouse antibodies. When indicated, Alexa 
Fluor 568 conjugated to phalloidin was added to simultaneously visualize F-actin. For 
nuclear staining, samples were incubated with DAPI (SIGMA) at 4 μg/mL in PBS for 
15 min at room temperature. The preparations were mounted on FluorSave reagent 
(Calbiochem) and visualized with a x63 objective using a Zeiss Axioplan fluorescence 
microscope (Göttingen, Germany) equipped with a cooled CCD camera (Leica DFC 
350 FX), or the Leica TCS-SP2-AOBS confocal microscope system. 
Statistical analysis
The results are expressed as the means ± SE. Differences between experimental 
groups when we evaluated the effect of more than one factor were assessed using the F-
test for the analysis of the variance. The significance of the differences between two 
conditions was determined using the student’s T-test for pair-wise comparisons. 
Significance was defined as p < 0.05.
6Results
Up-regulation of FXIII-A expression during in vitro monocyte differentiation into 
DCs
We first analyzed the expression of cellular FXIII-A in different human cell types 
using a semi-quantitative RT-PCR assay. FXIII-A was not amplified in HEK-293 cells. 
In K562 myeloid cells, the mRNA was present in very limited amounts, appreciated 
only after 35 cycles. In contrast, FXIII-A was readily detected in monocytes, though at a 
concentration approximately one magnitude less than in platelets as previously reported 
(Muszbek et al., 1999), and increased notably during the in vitro differentiation of 
monocytes to dendritic cells (DCs), where the expression levels relative to the -actin-
mRNA used as internal control was even higher than in platelets (Figs 1A and B).
Monocyte conversion into macrophages is accompanied by up-regulation of TG2, the 
most common TG family member (Murtaugh et al., 1983; Akimov and Belkin, 2001). 
Thus, we compared the relative expression of FXIII-A and TG2 in monocytes and DCs. 
As shown in Fig. 1C, FXIII-A and TG2 mRNA levels were very similar in monocytes, 
and differentiation to DCs was not associated with increased TG2 expression.
FXIII-A regulates migration of DCs
In order to explore the functional significance of FXIII-A up-regulation in monocyte-
derived DCs, we analyzed the effect of monodansyl-cadaverine (MDC), a competitive 
amino-donor for TG activity (Parameswaran et al., 1990), on cell migration using a 
transwell assay. In these experiments, DCs were first induced to mature and, 
consequently, express CCR7, which is required for cell migration (Sallusto et al., 1998). 
As shown in Fig. 2A, MDC inhibited both basal and CCL19-induced migration of DCs 
obtained from monocytes purified by either adhesion to serum-coated surfaces or 
immunomagnetic separation. Furthermore, FXIII-A-deficient DCs displayed normal 
endocytotic uptake of macromolecules like FITC-dextran particles (results not shown), 
but a significant reduction of transwell migration following CCL19 stimulation (Figs 2B 
and C). Together, these findings suggest a role for FXIII-A-derived TG activity on the 
regulation of DC migration.
FXIII-A overexpression promotes cell migration
CHO cells stably expressing FXIII-A were established as an alternative approach to 
analyze whether FXIII-A expression correlates with migratory cell behavior. Cell 
migration, assessed by transwell assays, was found significantly improved in cellular 
clones with a high proportion (>80%) of cells expressing FXIII-A compared with 
untransfected cells (Fig. 3A). To exclude clonal selection as a basis for the observed 
phenotypic difference, we analyzed individual cell migration in a pooled population 
with heterogeneous FXIII-A expression levels. Confocal microscopy analysis of the 
transwell membrane revealed a higher percent of cells expressing FXIII-A in layers 
corresponding to the lower side of the membrane, indicating that cell penetration 
through the membrane is enhanced in these cells (Fig. 3B).
Scratch-wound assays were also carried out to compare migration of untransfected 
and FXIII-A-transfected cells. As shown in Fig. 4, the rate of scratch closure was 
significantly higher in clonal cell populations expressing FXIII-A.
FXIII-A expression induces cell membrane blebbing
7Because maturation of DCs is associated with a reduced ability to spread on coated 
surfaces (Burns et al., 2004), we used immature DCs to analyze the localization pattern 
of FXIII-A. Confocal microscopy analysis revealed that, although broadly distributed, it 
shows a preferential localization in retracting uropods and membrane ruffles at the 
edges of protruding lamellae of migrating cells (Fig. 5A). In addition, it was also 
abundant in actin-rich rounded projections expanding from the plasma membrane that 
could correspond to membrane protrusions referred to as blebs (Charras et al., 2006)
(Fig. 5A).
Expression of TG2 in a fibroblast cell line has been reported to induce cell 
morphology changes and membrane blebbing (Gentile et al., 1992). Although plasma 
membrane blebs have been primarily associated with apoptotic and necrotic processes, 
recent evidences demonstrate its involvement in cell motility (Fackler and Grosse, 
2008). Thus, we found of interest to explore whether the increased migration observed 
in FXIII-A transfectants associated with the formation of plasma membrane blebs. 
Confocal microscopy analysis revealed that FXIII-A was present beneath the dorsal cell 
surface but not in optical sections that include the actin stress fiber-rich region in 
contact with the coverslip (Fig. 5B). In addition, a high number of FXIII-A-expressing 
cells displayed membrane blebbing with FXIII-A showing an additional marked 
compartmentalization inside the blebs (Fig. 5B). These membrane protrusions were also 
detected in FXIII-A-transfected cells migrating on two-dimensional surfaces (Fig. 4C). 
Their structure preservation during fixation and the recruitment of actin to the 
surrounding membrane may indicate that they are retracting blebs (Fig. 5C). In these 
cells, DAPI staining did not revealed changes in nuclear chromatin condensation related 
to cellular apoptotic or necrotic processes (results not shown).
8Discussion
Dendritic cells (DCs) represent a heterogeneous population of professional antigen-
presenting cells crucial for initiation and maintenance of T-cell-mediated immune 
responses. Immature DCs mainly home to areas of potential antigen entry, like skin and 
mucosa, where they exert a sentinel function taking up pathogens though pynocytosis 
and endocytosis (Banchereau and Steinman, 1998). Migration to lymph nodes to prime 
T cells requires cell phenotypic maturation including up-regulation of the chemokine 
receptor CCR7 (Sallusto et al., 1998; Allavena et al., 2000; Riol-Blanco et al., 2005). 
FXIII-A is expressed in different subsets of DCs including migratory dermal DCs 
(Nestle et al., 1993) and monocyte-derived DCs, which have a phenotype comparable to 
that of dermal DCs (Grassi et al., 1998). Recently, it has been localized in a subset of 
dermal cells showing a marked plasticity between tissue-resident dendritic cells (DCs) 
and macrophages (Zaba et al., 2007). In the present work, we show that FXIII-A mRNA 
is largely up-regulated during in vitro differentiation of human monocytes to DCs, 
reaching levels similar to those found in platelets. In contrast, the expression level of the 
most ubiquitous TG family member, TG2, did not change during this differentiation 
process, suggesting that TG activity in DCs basically relies on the presence of FXIII-A. 
However, expression of both TG2 and FXIII-A may account equally for TG activity in 
monocytes, in contrast with a previous report proposing FXIII-A as the predominant TG 
in these cells (Muszbek et al., 1988). It is worthy to note that microbial stimulation of 
DCs has been recently shown to downregulate FXIII-A expression (Torocsik et al., 
2005); however, FXIII-A protein was readily detected in the LPS-stimulated DCs used 
in our migratory assays.
So far, the functional significance of the high expression levels of FXIII-A in DCs 
remains elusive. In our study, a significant reduction of basal migration and chemotactic 
response to CCL19 was observed in DCs treated with the competitive TG inhibitor 
MDC, suggesting a role of cFXIII in regulating DC motility. Consistent with these data, 
the migratory response of FXIII-A-deficient DCs was reduced compared to that of 
control cells. It is known that intracellular rise of Ca2+ concentration is sufficient to 
trigger activation of FXIII (Polgar et al., 1990). Even though a rise in intracellular 
calcium appears to be dispensable for DC directional migration (Li et al., 2000), the 
strong and sustained calcium mobilization induced by CCL19 (Humrich et al., 2006)
may be directly linked to the role of FXIII-A in DC motility. On the other hand, TG 
activity of intracellular FXIII-A has been reported to crosslink agonist-induced AT1 
receptor homodimers in human monocytes, which correlated with enhanced adhesion to 
endothelial cells (AbdAlla et al., 2004). Whether this kind of mechanism could operate 
in other G-coupled protein receptors regulating specific receptor functions is unknown 
at the moment (Terrillon and Bouvier, 2004). At the CCL19 concentration used in these 
experiments the chemotactic response of DCs has been demonstrated to completely 
depend on the chemokine receptor CCR7 (Riol-Blanco et al., 2005). Thus, given the 
large upregulation of FXIII-A in monocyte-derived DCs, it is reasonable to consider the 
possibility that basal and/or stimulated TG activity could play a role in maintaining a 
level of CCR7 dimerization that, in turn, modulated the chemotactic response to 
CCL19.
A role for FXIII-A in cell motility is also supported by our results with a model of 
stably transfected cells. We show that overexpression of FXIII-A enhances cell 
migration in transwell and scratch-wound assays. Confocal microscopy analysis
revealed that a significantly higher number of FXIII-A-expressing cells displayed 
membrane blebbing with FXIII-A residing inside the blebs. Localization of actin at the 
9limiting membrane of the protrusion suggests that they are mainly retracting blebs. 
Blebs are dynamic spherical projections of the plasma membrane that are produced by 
local disruption of the membrane-actin cortex interaction (Charras et al., 2006). Its 
precise function both in normal and pathological situations is still unclear. Although 
blebs have been often considered to be a feature of apoptotic and necrotic processes, 
they are also observed during normal cell spreading. As well, recent evidences support 
an important role of non-apoptotic membrane blebbing in cell motility, providing a 
common alternative to lamellipodia-based migration in three-dimensional environments 
(Charras and Paluch, 2008; Fackler and Grosse, 2008). Signaling through Rho-ROCK-
myosin has been demonstrated to be involved in bleb contractility (Charras et al., 2006; 
Fackler and Grosse, 2008), but blebs can also be induced by a number of stimuli that 
disrupt membrane-actin cortex interactions (Fackler and Grosse, 2008).
Extensive cell blebbing and fragmentation have been observed in transfected 
fibroblasts expressing high levels of TG2 (Gentile et al., 1992). However, in the present 
study, the survival of blebbing cells and the apparent reversibility of blebs are 
compatible with its nonapoptotic nature. Interestingly, TG-induced transamidation and 
activation of RhoA is known to promote cytoskeletal rearrangement during neuronal 
differentiation (Singh et al., 2003). In addition, platelet FXIII-A uses serotonin as a 
substrate to transamidate RhoA during platelet aggregation (Walther et al., 2003). Thus, 
according to the distribution pattern of FXIII-A in our cell model, it is possible that 
local increases of TG activity triggered activation of the RhoA pathway at the site of 
blebbing. 
The severe bleeding phenotype caused by plasma FXIII deficiency makes difficult to 
determine whether patients with mutations in FXIII-A subunit present concurrent 
symptoms associated to the lack of cellular FXIII. Monocytes lacking FXIII-A showed 
impaired receptor-mediated phagocytic activities (Sarvary et al., 2004). In spite of this, 
increased susceptibility to infectious diseases has not been reported in patients with 
FXIII-A deficiency (Seitz et al., 1996). Taken together, the herein reported data suggest 
that up-regulation of FXIII-A during DC differentiation may be crucially involved in 
migration of mature DCs. Thus, although further studies are required to determine the 
precise function of cFXIII in the monocyte/macrophage lineage, this study suggests that 
impaired motility of DCs may represent an additional factor contributing to the 
phenotype in FXIII-A-deficient patients.
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Figure legends
Fig. 1. Semi-quantitative RT-PCR analysis of FXIII-A expression. (A) PCR-based 
relative quantification of FXIII-A mRNA was performed as described in ¨Materials and 
methods¨. The PCR products were resolved on agarose gels and visualized by ethidium 
bromide staining. The figure shows a representative experiment of three independent 
determinations. (B) The amplification products in a linear range were quantified by 
densitometry and expressed as FXIII-A/-actin ratios. (C) PCR-based relative 
quantification of FXIII-A and TG2 in monocytes and monocyte-derived DCs. A 
representative experiment of three independent assays is shown.
Fig. 2. Chemotaxis of control and FXIII-A-deficient DCs. (A) Effect of MDC on
basal and CCL19-induced chemotactic migration of monocyte-derived DCs. Cells were 
incubated with DMSO or MDC for 30 min at 37ºC and transwell migration assays were 
carried out as described in ¨Materials and methods¨. The figure shows representative 
results of three assays performed with monocytes separated by adhesion to serum and 
two assays performed with monocytes isolated by immunoselection. (B) 
Immunofluorescence analysis of FXIII-A expression in DCs from a control and a FXIII-
A-deficient patient. (C) Basal and CCL19-induced chemotactic migration of control and 
FXIII-A deficient DCs. The figure shows representative results of three independent 
transwell assays.
Fig. 3. Effect of FXIII-A overexpression in CHO cell migration.
(A) Transwell migration of control and FXIII-A expressing clonal CHO cells. Cells 
were allowed to migrate for 2 h at 37ºC and, then, collected and counted as described in 
¨Materials and methods¨. The results represent the mean + SD of three independent 
experiments. *, p < 0.05. (B) Transwell migration of pooled CHO cell transfectants. The 
cells were allowed to migrate for 2 h and, then, the transwell membrane was fixed and 
the cells labelled with anti-FXIII-A and DAPI, and analyzed by confocal microscopy 
through a 5 μm Z-axis. The figure shows a higher percent of cells expressing FXIII-A in 
layers corresponding to the lower side of the membrane. Representative results of three 
independent assays are shown. Green: FXIII-A; Blue: Nucleus. Bar: 47 μm.
Fig. 4. Effect of FXIII-A overexpression in migration of CHO cells on two-
dimensional surfaces. (A) Scratch-wound assays of untransfected and FXIII-A-
transfected CHO cells. Cells were wounded as described in “Materials and methods” 
and photographed immediately after wounding and 3, 6, and 9 h later. Migration was 
quantified by measuring the distance between the wound edges, and the results were 
expressed as the % of wound closure. The values are means + SE of four separate 
experiments. Significant differences between control and clonal CHO cells expressing 
FXIII-A were obtained. **, p < 0.01. (B) Microphotographs of a representative scratch-
wound assay with control and FXIII-A expressing cells (clone 1). (C) Membrane bleb-
like protrusions in FXIII-A-transfected cells migrating on a two-dimensional surface. 
Cells were platted on serum-coated coverslips, and scratch-wound assay and 
epifluorescence microscopy analysis were carried out as described in “Materials and 
methods¨ after 6 h.
Fig. 5. Membrane bleb-like protrusions in DCs and FXIII-A-transfected CHO 
cells. (A) Immature DCs, plated on polylisine-coated coverslips and incubated for 16 h, 
were stained with phalloidin and anti-FXIII-A polyclonal antibody, and imaged using 
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confocal microscopy. U, uropod; L, lamellipodium; B, bleb. (B) CHO cells expressing 
FXIII-A were plated on fibronectin-coated coverslips and, after 30 min, immunolabeled 
as described in ¨Materials and methods¨. The figure shows confocal microscopy images 
corresponding to serial z-sections in a representative cell. (C) Confocal microscopy 
analysis of a representative FXIII-A-transfected cell after 15 min of spreading on 
fibronectin. Boxed areas illustrate higher-magnification images of an individual bleb 
showing that FXIII-A resides inside and that F-actin is localized at the limiting 
membrane of the protrusion. Bars: 15 μm
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